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hand, the velamentous insertion represents 0.27% and the marginal insertion - 0.12%. Both of 
them are associated with massive blood loss at birth, hemorrhagic complications in the 
antenatal period, miscarriage, hypotonia and cyanosis in the newborn, difficulties in 
approaching the birth and sudden intrauterine death of the newborn caused by hypoxia. Furcate 
insertion of the umbilical cord was not found, because it has the lowest incidence, as other 
studies have shown. 
Conclusion. Even if the incidence of the pathological types of the umbilical cord insertion is 
low, the associated abnormalities are severe and must be taken into consideration. Thus, 
punctilious and continuous monitoring of the development of the pregnancy, including the 
analysis of the insertion type could help the obstetricians in providing professional medical 
assistance. It should be said that the formation of the umbilical cord is finished at 7 weeks of 
pregnancy. So, by using an ultrasonographic examination in the 1st trimester, between 12 and 
15 weeks, it is possible to determine the insertion type of the umbilical cord. To sum up, all the 
necessary precautions can be taken in time and pregnancy/birth-giving can occur 
physiologically, with no harm to the mother and fetus. 
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Introduction. Although the effects of placebo have been known in medicine for several 
centuries, the research of the underlying mechanisms has developed relatively recently. 
Consequently, in the last decades, numerous studies and researches have been published, most 
of them focused on symptoms such as pain, fatigue, nausea and itching.  
Aim of the study. To disclosure the main mechanisms underlying the placebo and nocebo 
effects.  
Materials and methods. The study was performed in the base of reviewes of various 
researches and scientific materials (articles in specialized journals, monographs and articles on 
the Internet etc.) that refer to placebo/nocebo effects description and observation.  
Results. The classical conditioning theory and the response expectancy model were considered 
for a long time the most accepted theories explaining the underlying processes of 
placebo/nocebo phenomena. Numerous researches revealed that suggestions, thoughts and 
beliefs could have an important influence on human body, thus giving rise to specific 
therapeutic processes. However, placebo and nocebo effects are not mediated only by 
psychological mechanisms. There is a clear evidence of neurobiological changes at different 
levels and areas of the brain, involving endogenous opioids, as well as dopamine, especially in 
the case of the analgesic placebo effect. Similarly, such neuromodulators as cholecystokinin 
play a significant role in the nocebo effect. The findings concerning the involvement of the 
genetic mechanisms in the process of manifesting placebo/nocebo effects cannot be neglected. 
In the last years, the studies reveal that genetic variations in the brain's neurotransmitter 
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pathways could influence placebo effects, the incipient evidence being provided with regard to 
existence of genes that mediate placebo effects in individual patients. Placebo/nocebo genetics 
is an area in which research is only in a quit early phase.  
Conclusions. The study results evoke the complexity of the placebo and implicitly nocebo 
phenomena and the difficulty of formulating a generally valid theory, which could explain in a 
clear and complete manner how they function. The described mechanisms have to be regarded 
in a complementary manner and must be analyzed and regarded as a whole. It is worth to 
continue the investigations of placebo/nocebo mechanisms so as to optimize the therapeutic 
interventions and to improve the design of clinical trials.  
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Introduction. According to World Health Organization report, cardiovascular diseases are the 
leading cause of mortality, accounting for 31% worldwide. Cardiac ischemia is the key-
mechanism that underlies acute coronary syndrome and induces cellular necrosis. Prolonged 
ischemia and hypoxia switch the myocardial metabolism from aerobic to anaerobic glucose 
degradation with increased lactate formation. The accumulation of lactate in cardiac myocytes 
results in acidosis, altered energy metabolism and cellular membrane damage. We suppose that 
myocardial ischemia could cause an elevation of circulating lactate level.  
Aim of the study. The research purpose was to evaluate serum lactate levels in experimental 
acute myocardial infarction.  
Materials and methods. Forty healthy adult male rats were randomly divided into five groups: 
(L1) - sham; (L2) - control NaCl 0.9% solution; and with acute myocardial infarction induced 
by subcutaneous injection of isoproterenol hydrochloride 100 mg/ kg (one dose), and sacrificed 
after 6 h (L3), 24 h (L4) and 7 days (L5) respectively. Serum lactate concentration was 
determined using standard kit (ELITech, France). Obtained data were represented by median 
and interquartile range. For group comparison, the Kruskal-Wallis and Dunn nonparametric 
tests were performed (SPSS 23.0). 
Results. The investigated groups have shown statistically insignificant difference for serum 
levels of lactate (p < 0.05). Initially in L3 was identified a slight decrease, followed by a 
significant increase in L4, with a repeated fall in L5 group. 
Conclusions.  The obtained data denote the possible release of lactate from the ischemic 
cardiomyocytes to the blood. Serum lactate level, following acute myocardial infarction is a 
useful biomarker that reflects the severity of tissue hypoxia. 
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